多药耐药菌感染肺炎直接的经济损失调查  

Investigation of the cost of hospital acquired pneumonia by multiple drug-resistant organisms

作　　者：林臻[1] 黄倩倩[1] 王萍[1] 韦倩[1] 刘雪琴[1] 

机构地区：[1]广西医科大学附属肿瘤医院感染管理科,广西南宁530021

出　　处：《中华医院感染学杂志》2016年第15期3577-3579,共3页Chinese Journal of Nosocomiology

基　　金：国家卫计委卫生公益性行业科研专项基金资助项目(201002021);广西壮族自治区卫计委科研基金资助项目(Z2014584)

摘　　要：目的探讨多药耐药菌(MDROs)与非MDROs感染肺炎直接经济损失和预后差异,为做好医院感染管理工作提供依据。方法收集2013年4月1日-10月31日,广西7所三甲医院MDROs及非MDROs感染肺炎患者共349例,根据感染病原菌分为MDROs组162例,非MDROs组187例,比较两组患者住院费用、住院时间和预后的差异,数据采用SPSS 16.0软件进行统计分析。结果 MDROs组患者住院费用较非MDROs组增加33090.26元,增加137.43%;MDROs组患者住院时间较非MDROs组延长9.43d、病死率上升6.79%,两组比较差异均有统计学意义(P<0.05)。结论 MDROs较非MDROs感染所造成的直接经济损失和预后影响更大,合理、谨慎地使用抗菌药物,进一步加强医院感染管理,落实医院感染预防和控制策略刻不容缓。OBJECTIVE To study the cost and prognosis of hospital acquired pneumonia（HAP）by multiple drugresistant organisms（MDROs）and non-multiple drug-resistant organisms（non-MDROs）,so as to improve the management of hospital infections.METHODS A total of 349 cases of patients with HAP in 7 3-grade hospitals in Guangxi from Apr.1st to Oct.31 st in 2013 were collected,and divided into MDROs group（n=162）and nonMDROs group（n=187）,according to pathogenic bacteria types.The cost,duration of hospitalization and prognosis of patients of the two groups were compared.The data were analyzed by SPSS 16.0.RESULTS Compared with non-MDROs group,MDROs group had higher cost of hospitalization（increased by 33090.26 yuan,137.43%）,longer duration of hospitalization（increased by 9.43days）,and higher death rate（increased by 6.79%）（P〈0.05）.CONCLUSION MDROs cause higher cost and worse prognosis than non-MDROs,we should rational use antibiotics properly and strengthen the management of hospital acquired infection,and we must put into effect of the strategies of prevention and control of the hospital acquired infection.

关 键 词：多药耐药菌 肺炎 医院感染 经济损失 

分 类 号：R563.1[医药卫生—呼吸系统]